Evidence map›Paper›PMID 24793238›Full record

ArticleNature medicine2014

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

Saul A Villeda, Kristopher E Plambeck, Jinte Middeldorp, Joseph M Castellano, Kira I Mosher, Jian Luo, Lucas K Smith, Gregor Bieri, Karin Lin, Daniela Berdnik and 8 more

4 registry-linked trialsAbstract read
In one paragraph

Article in Nature medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 646 papers.

0numbers the graph read from it
0cells of the map it votes in
646citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02460731 phase1completednot on this mapstarted 2015, after this paper: background citation

A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy

TypeinterventionalSponsorUniversity of California, San FranciscoRan2015 to 2019Enrolled6ConditionsProgressive Supranuclear PalsyArmsFresh Frozen Plasma
NCT02968433 phase1completednot on this mapstarted 2016, after this paper: background citation

The Stanford Parkinson's Disease Plasma (SPDP) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Moderate Parkinson's Disease

TypeinterventionalSponsorStanford UniversityRan2016 to 2019Enrolled16ConditionsParkinson Disease(PD)ArmsInfusions of young plasma
NCT03353597 phase1 / phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

TypeinterventionalSponsorChandra DuggiralaRan2018 to 2022Enrolled2,120ConditionsAgingArmsPlasma Transfusion
NCT04566757 phase1unknown statusnot on this mapstarted 2021, after this paper: background citation

Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline

TypeinterventionalSponsorAmerican Academy of Regenerative MedicineRan2021 to 2022Enrolled12ConditionsAge-related Cognitive DeclineArmsUmbilical Cord Blood Plasma
3 · Its place in the literature

Who cites it

646 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Extracellular vesicles and epigenetic aging clocks in tissue aging: an exosome-focused conceptual framework with a focus on skin.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Aged circulating CD8Immunity · 2026
    Article
  20. Review

586 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Saul A Villeda1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3] Neuroscience Graduate Program, University of California San Francisco, San Francisco, California, USA. [4] Biomedical Sciences Graduate Program, University of California San Francisco, San Francisco, California, USA. [5] Developmental and Stem Cell Biology Graduate Program, University of California San Francisco, San Francisco, California, USA. [6] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Kristopher E Plambeck1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3].
Jinte Middeldorp1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2].
Joseph M Castellano1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2].
Kira I Mosher1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2] Neuroscience Graduate Program, Stanford University School of Medicine, Stanford, California, USA. [3].
Jian LuoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000000220648467
Lucas K Smith1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA.
Gregor Bieri1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [4] Neuroscience Graduate Program, Stanford University School of Medicine, Stanford, California, USA.
Karin Lin1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3] Neuroscience Graduate Program, University of California San Francisco, San Francisco, California, USA.
Daniela BerdnikDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Rafael WablDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Joe Udeochu1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3] Biomedical Sciences Graduate Program, University of California San Francisco, San Francisco, California, USA.
Elizabeth G Wheatley1] Department of Anatomy, University of California San Francisco, San Francisco, California, USA. [2] The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, California, USA. [3] Developmental and Stem Cell Biology Graduate Program, University of California San Francisco, San Francisco, California, USA.
Bende ZouAfaSci Research Laboratory, Redwood City, California, USA.ORCID 0000000229073102
Danielle A SimmonsDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Xinmin S XieAfaSci Research Laboratory, Redwood City, California, USA.
Frank M LongoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Tony Wyss-Coray1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2] Neuroscience Graduate Program, Stanford University School of Medicine, Stanford, California, USA. [3] Center for Tissue Regeneration, Repair and Restoration, VA Palo Alto Health Care System, Palo Alto, California, USA.

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Training Program in Basic NeuroscienceT32MH020016 · NIMH · STANFORD UNIVERSITY · PI Justin L Gardner, Merritt C Maduke · 1997 to 2026
$16.2M
PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
PREDOCTORAL TRAINING IN BIOMEDICAL SCIENCEST32GM008568 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 1995 to 2019
$6.3M
Regulation of Neurogenesis and Cognition by Systemic Age-Related Immune FactorsDP5OD012178 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VILLEDA, SAUL A · 2012 to 2016
$1.8M
Circulatory Rejuvenating Factors for the BrainR01AG045034 · NIA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI WYSS-CORAY, TONY · 2013 to 2017
$1.4M
Regulation of Neural Stem Cells by Changes in the Aging Systemic EnvironmentF31AG034045 · NIA · STANFORD UNIVERSITY · PI VILLEDA, SAUL A · 2009 to 2011
$88k
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1-TR000004NCATS NIH HHS UL1 TR001085NCRR NIH HHS UL1 RR025744NCRR NIH HHS UL1-RR025744NIA NIH HHS 1F31-AG034045-01NIA NIH HHS AG03144NIA NIH HHS AG045034NIA NIH HHS F31 AG034045NIA NIH HHS R01 AG045034NICHD NIH HHS T32 HD007470NIGMS NIH HHS T32 GM008568NIH HHS DP5 OD012178NIH HHS DP5-OD1217NIMH NIH HHS T32 MH020016
6 · The paper itself

Abstract

As human lifespan increases, a greater fraction of the population is suffering from age-related cognitive impairments, making it important to elucidate a means to combat the effects of aging. Here we report that exposure of an aged animal to young blood can counteract and reverse pre-existing effects of brain aging at the molecular, structural, functional and cognitive level. Genome-wide microarray analysis of heterochronic parabionts--in which circulatory systems of young and aged animals are connected--identified synaptic plasticity-related transcriptional changes in the hippocampus of aged mice. Dendritic spine density of mature neurons increased and synaptic plasticity improved in the hippocampus of aged heterochronic parabionts. At the cognitive level, systemic administration of young blood plasma into aged mice improved age-related cognitive impairments in both contextual fear conditioning and spatial learning and memory. Structural and cognitive enhancements elicited by exposure to young blood are mediated, in part, by activation of the cyclic AMP response element binding protein (Creb) in the aged hippocampus. Our data indicate that exposure of aged mice to young blood late in life is capable of rejuvenating synaptic plasticity and improving cognitive function.

Indexed as

Age FactorsAgingAnimalsBlood TransfusionBlotting, WesternCell LineCognition DisordersCyclic AMP Response Element-Binding ProteinDNA PrimersHippocampusImmunohistochemistryMiceMice, Inbred C57BLMicroarray AnalysisNeuronal PlasticityParabiosisCyclic AMP Response Element-Binding ProteinDNA Primers

Identifiers

PMID24793238
PMCPMC4224436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.